Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor
by pfdietz on Tuesday January 25, 2022 @04:44AM
(#30070049)
I don't think 8.9 uM is a terribly good active concentration for a drug, so there is a lot of work to be done here.
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor
by _Wintermute on Tuesday January 25, 2022 @09:07AM
(#30071906)
I know CDK20 is a difficult target, otherwise presenting results where your best hit is at 9μM would be pretty disappointing.
It would be interesting to see the Kd values for the other CDK family members, there's no mention at all of specificity in their paper.
Should this molecule be successful (Wich is highly unlikely, as most hit targets aren't) it will probably take an decade until this becomes an experimental treatment, and likely two or more until it becomes a standard treatment.
All in all, this isn't really big news at all, this is a very unexciting thing, and only gets views because it has AlphaFold in the title
(Caveat: it's been a few years since I worked in a remotely related area)